Drug · DIN 00343617
ROFACT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 2, 2019; first marketed December 31, 1977.
- Drug Identification Number (DIN)
- 00343617
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Rifampicin J04AB02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIFAMPIN | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 2, 2019: NOC 22355New Drug Submission (NDS) · Administrative: Change in Product Ownership
- September 14, 2004: NOC 5354New Drug Submission (NDS) · Manufacturer name change
Other DINs named ROFACT
- DIN 00393444 · Marketed